Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: tktrimbath who wrote (502)	12/31/2006 7:01:35 PM
From: Mike McFarland	Respond to of 557

Very difficult to discern which companies will bounce and which trend down toward zero. Maybe the reverse split somehow salvaged it and some microcap funds bought in or something. The idea of localized inhibition of TNF rather than systemic therapy seems like a pretty smart way to push Tgen's platform, and AAV is harmless enough. I suppose we will have a pretty good idea if it works based on ASGT presentations next June. The meeting is here in Seattle apparently, May 30th to June 3rd--how about that. Nice timing if Tgen has the goods! Keep us posted if anything happens before that meeting and thanks for watching it for us! some free articles here if you're interested nature.com